DJIA 16,987.51 -61.49 -0.36%
NASDAQ 4,567.60 -24.21 -0.53%
S&P 500 1,985.54 -11.91 -0.60%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

41.29 0.42 (1.03%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $41.29 1.03%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.90
Previous Close $40.87
Daily Range $40.95 - $43.42
52-Week Range $22.25 - $62.66
Market Cap $4.9B
P/E Ratio -50.46
Dividend (Yield) $0.00 (0.0%)
Volume 5,211,510
Average Daily Volume 1,860,372
Current FY EPS -$0.70

Sector

Healthcare

Industry

Drugs

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

Why ISIS Pharmaceuticals Inc. Stock Is Flat in 2014

ISIS Pharmaceuticals shares have rebounded since spring, but still remain unchanged this year as investors digest a big stock move last year and wait for further proof that antisense RNA technology has blockbuster potential.

Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH

Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock

October 31st Options Now Available For Isis Pharmaceuticals (ISIS)

'Mad Money' Lightning Round: Buy, Buy, Buy Flextronics

Notable ETF Inflow Detected - IWM, ISIS, GPK, ULTI

Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog

3 Health Care Stocks Pushing The Sector Higher

Isis Pharmaceuticals, Inc. (ISIS) Surges: Stock Moves 10.8% Higher - Tale of the Tape

Isis Pharmaceuticals Finally Breaks Out

See More ISIS News...

ISIS's Top Competitors

ISIS $41.29 (1.03%)
Current stock: ISIS
AMGN $137.89 (-0.77%)
Current stock: AMGN
GILD $103.66 (-2.57%)
Current stock: GILD
BIIB $323.39 (-1.14%)
Current stock: BIIB